Ocera Therapeutics Inc (NASDAQ:OCRX)

5.65
Delayed Data
As of Feb 27
 -0.105 / -1.83%
Today’s Change
4.47
Today|||52-Week Range
17.01
-11.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues8.5M10.2M8.4M85.0K
 
 
 
 
 
Depreciation And Amortization265.0K308.0K332.0K324.0K
 
 
 
 
 
 
Operating ExpensesGross Income8.3M-----239.0K
 
 
 
General Expenses13.7M30.6M27.2M12.0M
 
 
 
 
 
Research And Development10.1M24.9M21.0M3.5M
 
 
 
 
 
Total Operating Expenses14.0M30.9M27.5M12.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.4M-20.7M-19.1M-12.3M
 
 
 
 
 
Extraordinary Credit0.000.000.0015.0K
 
 
Extraordinary Charge-333.0K0.00-1.4M-3.1M
 
 
 
 
Interest Expense On Debt1.5M1.6M2.4M193.0K
 
 
 
 
 
Other Expenses595.0K126.0K27.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.6M-22.2M-22.8M-15.5M
 
 
 
 
 
Discontinued Operations0.000.000.00-1.9M
 
 
Extraordinary Items0.000.000.00-86.0K
 
 
Net Income-6.6M-22.2M-22.8M-17.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS842.0K1.5M2.1M6.1M
 
 
 
 
 
Shares To Calculate EPS Diluted842.0K1.5M2.1M6.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$7.92-$14.64-$10.80-$2.85
 
 
 
 
 
EPS Diluted-$7.92-$14.64-$10.80-$2.84
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account